AMBIFUL sol inj 250 mg/5ml ser pré 2 pce
7680675120024
CH-67512
L02BA03
07.16.2.
Active substances:
1 / 3
google
Details
- Product number
- 6751201
- CPT
- -
- Packaging group
- 2
- Unit
- Fertigspritze(n)
- Composition
- fulvestrantum 50 mg, ethanolum 96 per centum 100 mg, alcohol benzylicus 100 mg, benzylis benzoas 150 mg, ricini oleum virginale, q.s. ad solutionem pro 1 ml.
Articles (1)
Ambiful 250 mg/5 ml, Injektionslösung in einer Fertigspritze
Injektionslösung
2
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
fulvestrantum
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
ethanolum 96 per centum
|
100.0 MG | Substance | HBESI |
|
alcohol benzylicus
|
100.0 MG | Substance | HBESI |
|
benzylis benzoas
|
150.0 MG | Substance | HBESI |
|
ricini oleum virginale
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 329.05
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/04/2021
Authorization holder
Curatis AG
4410 Liestal
Authorization information
- Swissmedic authorization number
- 67512
- Drug name
- AmbiFul, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- L02BA03
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 10/02/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- AMBIFUL sol inj 250 mg/5ml ser pré 2 pce
- Description (DE)
- AMBIFUL Inj Lös 250 mg/5ml Fertspr 2 Stk
- Market launch
- 10/02/2020
- Narcotic (BTM)
- No